For more information, you can refer to Skyrizi’s prescribing information. Mild side effects of Skyrizi can include: These side effects may be temporary, lasting a few days or weeks. But if the ...

Patients with moderate to severe Crohn’s disease who did not achieve clinical response to IV induction with Skyrizi ...

New data with AbbVie’s IL-23 inhibitor Skyrizi suggests it can alleviate symptoms in psoriasis patients who don’t respond well to other biologics for the skin disease, including widely-used IL ...

Skyrizi (risankizumab) is the first IL-23-selective drug to be cleared for the inflammatory bowel disease – ahead of rivals like Johnson & Johnson's Tremfya (guselkumab), and Sun Pharma's Ilumya ...

"JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized hole" was originally created and published by ...